Human Cardiomyocyte Progenitor Cells in Co-culture with Rat Cardiomyocytes Form a Pro-arrhythmic Substrate: Evidence for Two Different Arrhythmogenic Mechanisms

Frontiers in Physiology
Nicoline W SmitRuben Coronel

Abstract

Background: Cardiomyocyte progenitor cells (CMPCs) are a promising cell source for regenerative cell therapy to improve cardiac function after myocardial infarction. However, it is unknown whether undifferentiated CMPCs have arrhythmogenic risks. We investigate whether undifferentiated, regionally applied, human fetal CMPCs form a pro-arrhythmic substrate in co-culture with neonatal rat ventricular myocytes (NRVMs). Method: Unipolar extracellular electrograms, derived from micro-electrode arrays (8 × 8 electrodes) containing monolayers of NRVMs (control), or co-cultures of NRVMs and locally seeded CMPCs were used to determine conduction velocity and the incidence of tachy-arrhythmias. Micro-electrodes were used to record action potentials. Conditioned medium (Cme) of CMPCs was used to distinguish between coupling or paracrine effects. Results: Co-cultures demonstrated conduction slowing (5.6 ± 0.3 cm/s, n = 50) compared to control monolayers (13.4 ± 0.4 cm/s, n = 26) and monolayers subjected to Cme (13.7 ± 0.6 cm/s, n = 11, all p < 0.001). Furthermore, co-cultures had a more depolarized resting membrane than control monolayers (-47.3 ± 17.4 vs. -64.8 ± 7.7 mV, p < 0.001) and monolayers subjected to Cme (-64.4 ± 8.1 mV, p < 0.00...Continue Reading

References

Sep 3, 2002·Computer Methods and Programs in Biomedicine·Mark PotseCornelis A Grimbergen
Jun 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bertrand LeobonSerge Charpak
Jul 1, 1960·Circulation Research·W E SAMSON, A M SCHER
Sep 25, 2003·Cell·Antonio P BeltramiPiero Anversa
Oct 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hidemasa OhMichael D Schneider
Oct 28, 2003·The Journal of Physiology·Jürgen F HeubachUrsula Ravens
Apr 20, 2004·Cardiovascular Research·Stephan Rohr
Oct 9, 2004·Circulation Research·Elisa MessinaAlessandro Giacomello
Feb 11, 2005·Nature·Karl-Ludwig LaugwitzKenneth R Chien
Jul 9, 2005·Nature Biotechnology·Michael A Laflamme, Charles E Murry
Oct 22, 2013·Pharmacology & Therapeutics·Nima Milani-Nejad, Paul M L Janssen
Jan 17, 2015·Journal of the American College of Cardiology·Samuel GolpanianJoshua M Hare

❮ Previous
Next ❯

Citations

Aug 15, 2018·Scientific Reports·Angela Di BaldassarreBarbara Ghinassi
Feb 17, 2021·ACS Biomaterials Science & Engineering·Luis Eduardo Portillo Esquivel, Boyang Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence

Software Mentioned

GraphPad Prism
Leica Application Suite Advanced Fluorescence
MATLAB

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.